Gowen Maxine
- SEC CIK
- 0001280044
No open-market purchases or sales filed in the past year.
Current role at each company
- ACRS Aclaris Therapeutics, Inc.Directoras of Jun 8, 2026
- PASG Passage BIO, Inc.Directoras of May 21, 2026
- MRUS Merus N.V.Directoras of Dec 12, 2025
- ACGN Aceragen, Inc.Directoras of Aug 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gowen Maxine as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACGN Aceragen, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 (view filing) | Aug 10 | 1 day | Gowen MaxineDirector | SSale | −51 | $0.51 | −$26.01 | −100.0%0 after |